Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Patin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|June 30, 2016
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotectionH Blasco, F Patin, C R Andres, et al.
European Journal of Neurology|January 30, 2016
Metabolomics in amyotrophic lateral sclerosis: how far can it take us?H Blasco, F Patin, B Madji Hounoum, et al.
Journal of the Neurological Sciences|September 6, 2017
Low IDL-B and high LDL-1 subfraction levels in serum of ALS patientsJ B Delaye, F Patin, E Piver, et al.
European Journal of Clinical Nutrition|April 20, 2017
A decrease in blood cholesterol after gastrostomy could impact survival in ALSH Blasco, F Patin, S Molinier, et al.
Clinical Biochemistry|July 25, 2016
Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU managementC Bruno, D Dufour-Rainfray, F Patin, et al.
Clinical Biochemistry|April 4, 2017
Erratum to "Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management" [Clin. Biochem. 49 (2016) 1047-1050]C Bruno, D Dufour-Rainfray, F Patin, et al.
European Journal of Neurology|June 23, 2015
Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosisF Patin, P Corcia, B Madji Hounoum, et al.
Scientific Reports|December 17, 2017
Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALSH Blasco, C Veyrat-Durebex, C Bocca, et al.
JIMD Reports|June 15, 2016
A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in PhenylketonuriaH Blasco, C Veyrat-Durebex, M Bertrand, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 24, 2017
The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?C Bruno, F Patin, C Bocca, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|June 30, 2016
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotectionH Blasco, F Patin, C R Andres, et al.
European Journal of Neurology|January 30, 2016
Metabolomics in amyotrophic lateral sclerosis: how far can it take us?H Blasco, F Patin, B Madji Hounoum, et al.
Journal of the Neurological Sciences|September 6, 2017
Low IDL-B and high LDL-1 subfraction levels in serum of ALS patientsJ B Delaye, F Patin, E Piver, et al.
European Journal of Clinical Nutrition|April 20, 2017
A decrease in blood cholesterol after gastrostomy could impact survival in ALSH Blasco, F Patin, S Molinier, et al.
Clinical Biochemistry|July 25, 2016
Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU managementC Bruno, D Dufour-Rainfray, F Patin, et al.
Clinical Biochemistry|April 4, 2017
Erratum to "Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management" [Clin. Biochem. 49 (2016) 1047-1050]C Bruno, D Dufour-Rainfray, F Patin, et al.
European Journal of Neurology|June 23, 2015
Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosisF Patin, P Corcia, B Madji Hounoum, et al.
Scientific Reports|December 17, 2017
Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALSH Blasco, C Veyrat-Durebex, C Bocca, et al.
JIMD Reports|June 15, 2016
A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in PhenylketonuriaH Blasco, C Veyrat-Durebex, M Bertrand, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 24, 2017
The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?C Bruno, F Patin, C Bocca, et al.
Pageof 2